Buy Recommendation The Australian, page-7

Worth noting is that, of the 60 ASX stocks recommended in The Australian’s wealth ideas for 2018, only two biotechs made it to the list - Phosphagenics and Anatara Lifesciences (which is developing oral, non-antibiotic products for food animals).

In addition, of the 60 stocks, only five were highlighted with a 2017 graph and current stockprice graphic. POH was one of these five.

Finally, this recommendation has come from the typically sceptical Tim Boreham (New Criterion). Boreham is well acquainted with the POH story, having both covered, and sunk the boot into the company, over a number of years.